Treatment involves liver disease, cancer, diabetes, respiratory, cardiovascular and cerebrovascular diseases, anti infection, digestive, nervous and other diseases.
institutions predict that in 2017 the scale of China's health industry was 4 trillion and 900...
medical insurance settlement in the province has been fully realized. Ministry of human resou...
Recently, the office of the CPC Central Committee and the State Council issued the "on the reform of...
According to the State Food and Drug Administration website news, the 28 departments of the State De...
Future product
In the research of more than 200 products, focus on liver disease, tumor, anti infection, respiratory and hypoglycemic etc..
View Details
R & D results
The patent application of more than 400 national, provincial major science and technology projects of more than 50.
View Details
Scientific research cooperation
Shanghai Medical Institute and other units to cooperate to establish 5 joint laboratories, reached a number of international and domestic cooperation
View Details
Research and development overview
Research Institute under the Nanjing branch, Lianyungang branch, national enterprise technology center has a number of high-level R & D platform.
View Details
Pharmaceutical Group Social Responsibility Report
Corporation Social Responsibility Report
Scan access phone WeChat
WeChat public number
蘇公網安備 32108802010263号
